metformin glp-1 combination weight loss The role of receptor agonists as agents in patients with and without type 2 diabetes 2 Month Metformin Weight Loss

354 GLP-1RAs and musculoskeletal health GLP-1RAs and bone The quality of bone depends on bone metabolism, and the main factors affecting bone metabolism include osteoclasts, osteoblasts, and calcitonin

Under physiological conditions, postprandial GIP levels are approximately 3 4 times higher in molar concentration compared to GLP-1, irrespective of diabetic status (39)

It is informed adjustment

J Endocrinol (2011) 209(2):20310.10.1530/JOE-11-0015 10 MaXMengJJiaMBiLZhouYWangYet alExendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats

Dosing frequency and administration preferences significantly impact adherence and patient satisfaction

The fact that patients in this trial continued to lose weight after gastrointestinal adverse effects had subsided suggests that these effects were not the cause of weight loss